Development of PROTACs for targeted degradation of oncogenic TRK fusions
Saurav Kumar, Jiewei Jiang, Mia S. Donald-Paladino, Joy Chen, Andrea Gutierrez, Alexander Joel Federation, Frank Szulzewsky, Eric C. Holland, Fleur M. Ferguson, Behnam Nabet
This paper develops PROTACs to degrade oncogenic TRK fusions, showing improved efficacy compared to traditional inhibitors.
RSC Chemical Biology · Jan 1, 2026Peer-reviewedCancer Biology